262 related articles for article (PubMed ID: 26898069)
1. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
[TBL] [Abstract][Full Text] [Related]
2. The influence of isorel on the advanced colorectal cancer.
Cazacu M; Oniu T; Lungoci C; Mihailov A; Cipak A; Klinger R; Weiss T; Zarkovic N
Cancer Biother Radiopharm; 2003 Feb; 18(1):27-34. PubMed ID: 12667306
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
4. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.
Enesel MB; Acalovschi I; Grosu V; Sbarcea A; Rusu C; Dobre A; Weiss T; Zarkovic N
Anticancer Res; 2005; 25(6C):4583-90. PubMed ID: 16334146
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
Eisenbraun J; Scheer R; Kröz M; Schad F; Huber R
Phytomedicine; 2011 Jan; 18(2-3):151-7. PubMed ID: 20724129
[TBL] [Abstract][Full Text] [Related]
6. An overview on anticancer activities of the Viscum album extract Isorel.
Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
[TBL] [Abstract][Full Text] [Related]
7. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
[TBL] [Abstract][Full Text] [Related]
8. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
10. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
11. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
12. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic and proteomic insight into the effects of a defined European mistletoe extract in Ewing sarcoma cells reveals cellular stress responses.
Twardziok M; Meierhofer D; Börno S; Timmermann B; Jäger S; Boral S; Eggert A; Delebinski CI; Seifert G
BMC Complement Altern Med; 2017 Apr; 17(1):237. PubMed ID: 28454538
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
15. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
[TBL] [Abstract][Full Text] [Related]
16. Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.
Büssing A; Stumpf C; Tröger W; Schietzel M
Anticancer Res; 2007; 27(4C):2903-10. PubMed ID: 17695469
[TBL] [Abstract][Full Text] [Related]
17. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.
Thronicke A; Steele ML; Grah C; Matthes B; Schad F
BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435
[TBL] [Abstract][Full Text] [Related]
18. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
[TBL] [Abstract][Full Text] [Related]
19. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
[TBL] [Abstract][Full Text] [Related]
20. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]